Pregabalin as adjunctive therapy for partial epilepsy: An audit study in 96 patients from the South East of England

Seizure

Volumn 18, Issue 6, 2009, Pages 450-452

  Valentin, A ^a   Moran, N ^b,c   Hadden, R ^c,d   Oakes, A ^e   Elwes, R ^c   Delamont, R ^c,f   Mullatti, N ^c   Nashef, L ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KENT AND CANTERBURY HOSPITAL   (United Kingdom)

^c KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^d MAIDSTONE AND TUNBRIDGE WELLS NHS TRUST   (United Kingdom)

^e KENT AND MEDWAY NHS AND SOCIAL CARE PARTNERSHIP TRUST   (United Kingdom)

^f DARTFORD AND GRAVESHAM NHS TRUST   (United Kingdom)

Author keywords

AED; Audit; Partial epilepsy; Pregabalin; Therapy

Indexed keywords

PREGABALIN;

ADD ON THERAPY; ADJUVANT THERAPY; ADULT; AGED; AMNESIA; ANXIETY; ARTICLE; COGNITIVE DEFECT; DISEASE DURATION; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FOCAL EPILEPSY; FOLLOW UP; HALLUCINATION; HEADACHE; HEART PALPITATION; HUMAN; IRRITABILITY; LEG PAIN; LIMB PAIN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NAUSEA; OUTPATIENT DEPARTMENT; PERIPHERAL EDEMA; PRIORITY JOURNAL; PRURITUS; RASH; SEIZURE; SIDE EFFECT; TACHYCARDIA; TREATMENT RESPONSE; UNITED KINGDOM; WEIGHT GAIN; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; ENGLAND; EPILEPSIES, PARTIAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; LONGITUDINAL STUDIES; MALE; MEDICAL AUDIT; MIDDLE AGED; OUTPATIENTS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 67349227199     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2009.01.001     Document Type: Article

References (17)

1. Taylor C.P., Angelotti T., and Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res 73 (2007) 137-150
2. French J.A., Kugler A.R., Robbins J.L., Knapp L.E., and Garofalo E.A. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 60 (2003) 1631-1637
3. Arroyo S., Anhut H., Kugler A.R., Lee C.M., Knapp L.E., Garofalo E.A., et al. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 45 (2004) 20-27
4. Brodie M.J. Pregabalin as adjunctive therapy for partial seizures. Epilepsia 45 Suppl 6 (2004) 19-27
5. Elger C.E., Brodie M.J., Anhut H., Lee C.M., and Barrett J.A. Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study. Epilepsia 46 (2005) 1926-1936
6. Beydoun A., Uthman B.M., Kugler A.R., Greiner M.J., Knapp L.E., and Garofalo E.A. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 64 (2005) 475-480
7. Richter R.W., Portenoy R., Sharma U., Lamoreaux L., Bockbrader H., and Knapp L.E. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 6 (2005) 253-260
8. Rosenstock J., Tuchman M., Lamoreaux L., and Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 110 (2004) 628-638
9. Dworkin R.H., Corbin A.E., Young Jr. J.P., Sharma U., Lamoreaux L., Bockbrader H., et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 60 (2003) 1274-1283
10. Sabatowski R., Galvez R., Cherry D.A., Jacquot F., Vincent E., Maisonobe P., et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 109 (2004) 26-35
11. Crofford L.J., Rowbotham M.C., Mease P.J., Russell I.J., Dworkin R.H., Corbin A.E., et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52 (2005) 1264-1273
12. Feltner D., Wittchen H.U., Kavoussi R., Brock J., Baldinetti F., and Pande A.C. Long-term efficacy of pregabalin in generalized anxiety disorder. Int Clin Psychopharmacol 23 (2008) 18-28
13. Feltner D.E., Crockatt J.G., Dubovsky S.J., Cohn C.K., Shrivastava R.K., Targum S.D., et al. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharmacol 23 (2003) 240-249
14. Pande A.C., Feltner D.E., Jefferson J.W., Davidson J.R., Pollack M., Stein M.B., et al. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. J Clin Psychopharmacol 24 (2004) 141-149
15. Pande A.C., Crockatt J.G., Feltner D.E., Janney C.A., Smith W.T., Weisler R., et al. Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Am J Psychiatry 160 (2003) 533-540
16. Pohl R.B., Feltner D.E., Fieve R.R., and Pande A.C. Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing. J Clin Psychopharmacol 25 (2005) 151-158
17. Carreno M., Maestro I., Molins A., Donaire A., Falip M., Becerra J.L., et al. Pregabalin as add-on therapy for refractory partial seizures in every day clinical practice. Seizure 16 (2007) 709-712